Alexandra Tolia is an independent strategic advisor to biotech companies. Previously, Alexandra led investments in private and public companies as a Partner at venture capital firm Fund+, at PMV and Hunza Ventures, where she built strong VC portfolios in Life Sciences in Europe and the US. She holds a PhD in Medical Sciences from the KU Leuven, followed by a postdoctoral fellowship at UCSF, and an executive degree in General Management from the Solvay Brussels School of Economics and Management. Alexandra is the author of high impact publications in the fields of neurodegeneration and cardiovascular disease and has served as board member in several companies active in biotech, diagnostics and medical technologies.

This website uses cookies to ensure you get the best experience on our website. Get more details by clicking on the Button below.